BCAB vs COP · $5.9M cap vs P/E 19, rev $58.94B
Bioatla Inc (BCAB) versus ConocoPhillips (COP) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
BCAB currently screens at market cap $5.9M. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Not investment advice. Open the BCAB and COP stock pages for the full models.
Not investment advice.